Advertisement
MDT vs STE
Which Stock Would AI Choose? Medtronic (MDT) vs. Steris (STE) Stock Comparison
Key Takeaways
- MDT and STE operate in the healthcare sector with MDT focused on broad medical devices and STE specializing in infection prevention and sterilization services.
- Recent market activity shows MDT posting stronger one-month gains compared to STE, which experienced more modest or flat movements amid earnings updates.
- Both companies maintain solid balance sheets, with MDT offering a higher dividend yield and STE demonstrating consistent organic revenue growth in recent quarters.
- Sector exposure differs notably: MDT spans multiple therapeutic areas while STE benefits from recurring demand in sterilization and procedural support.
- Market sentiment remains neutral to cautious for both amid broader healthcare valuations, with MDT showing relatively better price stability in recent weeks.
- Relative performance highlights trade-offs in scale, with MDT as a larger-cap name versus STE’s more specialized, higher-growth profile.
Introduction
Medtronic (MDT) and Steris (STE) represent two established healthcare companies with distinct yet complementary business models in the medical technology space. This comparison examines their recent stock behavior, operational drivers, and market positioning to assist investors and traders evaluating relative opportunities within the sector. The analysis focuses on observable performance metrics, sector dynamics, and sentiment indicators over recent weeks, providing a factual basis for understanding how these stocks have responded to current market conditions. Traders seeking exposure to medical devices or infection-control solutions, as well as those comparing large-cap stability against specialized growth, may find this review relevant for portfolio considerations.
MDT Overview and Recent Performance
Medtronic (MDT) is a leading medical device company developing therapies for chronic conditions across cardiovascular, diabetes, neurological, and other areas. In recent market activity, the stock has shown resilience with gains of approximately 6% over the past month, though year-to-date returns remain negative in the low single digits. Broader influences include ongoing product pipeline updates and steady demand for its established device portfolio. Sentiment has been supported by the company’s scale and dividend profile, contributing to relatively stable trading patterns amid healthcare sector fluctuations. Market capitalization stands near $117 billion, reflecting its position as one of the larger players in the industry.
STE Overview and Recent Performance
Steris (STE) provides infection prevention, sterilization, and surgical support products and services, serving hospitals and other healthcare facilities with a high proportion of recurring revenue. Recent performance has been mixed, with the stock trading near $234 following its August earnings release that featured an earnings-per-share beat alongside solid revenue figures. Year-to-date returns have been negative in the mid-single digits, while shorter-term movements showed limited upside in recent weeks. Key developments include investments in capacity expansion and consistent organic growth, which have helped maintain operational momentum despite broader market pressures on valuations. The company’s market capitalization approximates $23 billion.
Trending AI Robots
Tickeron’s Trending AI Robots page curates a selection of high-performing AI trading bots from a library of hundreds that analyze and trade thousands of tickers across global markets. Only those demonstrating strong suitability for prevailing conditions, including consistent historical results and adaptive strategies, are featured in the trending section. Available bots span diverse trading styles, timeframes, risk parameters, and performance statistics, with many reporting win rates, profit factors, and drawdown metrics in varying ranges depending on the specific model. This curated approach allows users to explore automated strategies tailored to different market environments. For more details on current trending options, visit Trending AI Robots.
Head-to-Head Comparison
In business models, MDT offers broad exposure across multiple medical device categories while STE concentrates on sterilization and procedural support with a higher recurring-revenue component. Growth drivers for MDT center on innovation in established therapies, whereas STE benefits from regulatory-driven demand for infection control. Recent momentum favors MDT with stronger monthly gains, though both have faced year-to-date headwinds. Risk factors include regulatory and reimbursement pressures for MDT and acquisition integration alongside capacity investments for STE. Sector exposure places both in healthcare, yet STE exhibits more specialized positioning. Market sentiment appears balanced, with neither showing pronounced outperformance relative to peers in recent activity.
Tickeron AI Verdict
Based on observable factors such as recent price consistency, earnings delivery, and relative positioning within the healthcare sector, Tickeron’s AI models may exhibit a modest probabilistic preference for MDT at present. The stock’s stronger short-term momentum and larger operational scale provide a measure of stability compared to STE’s more variable recent trajectory. However, outcomes remain dependent on evolving market conditions, and no definitive superiority is implied.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Disclaimers and LimitationsTo compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDT is a Hold and STE is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MDT’s FA Score shows that 1 FA rating(s) are green whileSTE’s FA Score has 1 green FA rating(s).
- MDT’s FA Score: 1 green, 4 red.
- STE’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MDT’s TA Score shows that 3 TA indicator(s) are bullish while STE’s TA Score has 3 bullish TA indicator(s).
- MDT’s TA Score: 3 bullish, 5 bearish.
- STE’s TA Score: 3 bullish, 5 bearish.
Price Growth
MDT (@Medical/Nursing Services) experienced а +0.99% price change this week, while STE (@Medical/Nursing Services) price change was -2.87% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -5.01%. For the same industry, the average monthly price growth was -0.34%, and the average quarterly price growth was -4.73%.
Reported Earning Dates
MDT is expected to report earnings on Nov 24, 2026.
STE is expected to report earnings on Nov 11, 2026.
Industries' Descriptions
@Medical/Nursing Services (-5.01% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| MDT | STE | MDT / STE | |
| Capitalization | 118B | 22.4B | 527% |
| EBITDA | 9.81B | 1.59B | 615% |
| Gain YTD | -2.531 | -8.915 | 28% |
| P/E Ratio | 24.68 | 28.07 | 88% |
| Revenue | 36.4B | 5.94B | 613% |
| Total Cash | 9.22B | N/A | - |
| Total Debt | 28B | 2.09B | 1,342% |
MDT | STE | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 79 | 55 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 4 Undervalued | 8 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 82 | |
SMR RATING 1..100 | 71 | 66 | |
PRICE GROWTH RATING 1..100 | 46 | 51 | |
P/E GROWTH RATING 1..100 | 49 | 74 | |
SEASONALITY SCORE 1..100 | 75 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MDT's Valuation (4) in the Medical Specialties industry is in the same range as STE (8). This means that MDT’s stock grew similarly to STE’s over the last 12 months.
STE's Profit vs Risk Rating (82) in the Medical Specialties industry is in the same range as MDT (100). This means that STE’s stock grew similarly to MDT’s over the last 12 months.
STE's SMR Rating (66) in the Medical Specialties industry is in the same range as MDT (71). This means that STE’s stock grew similarly to MDT’s over the last 12 months.
MDT's Price Growth Rating (46) in the Medical Specialties industry is in the same range as STE (51). This means that MDT’s stock grew similarly to STE’s over the last 12 months.
MDT's P/E Growth Rating (49) in the Medical Specialties industry is in the same range as STE (74). This means that MDT’s stock grew similarly to STE’s over the last 12 months.
| MDT | STE | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 65% | 2 days ago 57% |
| Stochastic ODDS (%) | 2 days ago 41% | 2 days ago 59% |
| Momentum ODDS (%) | 2 days ago 47% | 2 days ago 56% |
| MACD ODDS (%) | 2 days ago 59% | 2 days ago 50% |
| TrendWeek ODDS (%) | 2 days ago 55% | 2 days ago 56% |
| TrendMonth ODDS (%) | 2 days ago 49% | 2 days ago 48% |
| Advances ODDS (%) | 15 days ago 52% | 15 days ago 49% |
| Declines ODDS (%) | 9 days ago 57% | 2 days ago 57% |
| BollingerBands ODDS (%) | 2 days ago 66% | 7 days ago 69% |
| Aroon ODDS (%) | 2 days ago 33% | 2 days ago 49% |
Advertisement